5-HT2A antagonist (Alcon)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT2A antagonist (Alcon)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophreniaFeeding and Eating DisordersAnxiety Disorders +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlcon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlcon Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaFeeding and Eating DisordersAnxiety Disorders +[7] 

Other Information

ATC CodeN/A
Related LinksN/A